NCT06918743View on ClinicalTrials.gov

To Evaluate the Efficacy and Safety of RSS0393 Ointment in Patients With Plaque Psoriasis Phase II Study

PHASE2Not yet recruitingINTERVENTIONAL

Enrollment

147

Participants

Timeline

Start Date

April 30, 2025

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2026

Conditions

Psoriatic Subjects

Interventions

DRUG

RSS0393 ointment

RSS0393 ointment 0.01%

DRUG

RSS0393 ointment

RSS0393 ointment 0.03%

DRUG

RSS0393 ointment placebo

RSS0393 ointment placebo

All Listed Sponsors

lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY